BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Dec. 02, 2023	Nov. 30, 2024	Dec. 02, 2023
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,774.5	$ 18,557.3	$ 61,591.4	$ 60,898.2
Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,774.5	$ 18,557.3	$ 61,591.4	$ 60,898.2
Percentage of total net sales and other revenue	100.00%	100.00%	100.00%	100.00%
Non-perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 9,299.9	$ 9,242.8	$ 30,618.9	$ 30,566.5
Percentage of total net sales and other revenue	49.50%	49.80%	49.70%	50.20%
Fresh | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 5,735.2	$ 5,709.0	$ 19,557.5	$ 19,517.7
Percentage of total net sales and other revenue	30.50%	30.80%	31.80%	32.00%
Pharmacy | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 2,581.9	$ 2,282.8	$ 7,336.7	$ 6,323.9
Percentage of total net sales and other revenue	13.80%	12.30%	11.90%	10.40%
Fuel | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 885.2	$ 1,046.7	$ 3,157.4	$ 3,573.9
Percentage of total net sales and other revenue	4.70%	5.60%	5.10%	5.90%
Other | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 272.3	$ 276.0	$ 920.9	$ 916.2
Percentage of total net sales and other revenue	1.50%	1.50%	1.50%	1.50%